Related Experiment Video

Updated: Jun 18, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Amalia Baroutidou1, Nikolaos Otountzidis1, Andreas S Papazoglou2

  • 1First Department of Cardiology AHEPA University Hospital, Aristotle University of Thessaloniki Thessaloniki Greece.

Journal of the American Heart Association
|January 9, 2024
PubMed

Insights

Managing atrial fibrillation (AF) in adults with congenital heart disease (CHD) is complex. This review covers AF pathophysiology, risk factors, and ablation challenges in adult CHD patients, highlighting future research directions.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) prevalence is rising in adults with congenital heart disease (CHD).
  • Unique patient anatomy and physiology complicate AF management and ablation.
  • Existing knowledge on AF pathophysiology and risk factors in this population is limited.

Purpose of the Study:

  • To provide an overview of AF pathophysiology and risk factors in adult CHD.
  • To discuss the challenges associated with AF ablation in adult CHD patients.
  • To summarize current evidence on AF ablation safety and efficacy in specific adult CHD conditions.

Main Methods:

  • Literature review of AF in adult congenital heart disease.
  • Focus on pathophysiology, risk factors, and ablation challenges.
  • Summary of evidence for specific congenital heart defects: ASD, Ebstein anomaly, ToF, Fontan circulation.

Main Results:

  • AF management in adult CHD is challenging due to complex cardiac structures.
  • Emerging imaging and ablation techniques may offer new therapeutic avenues.
  • Evidence on AF ablation safety and efficacy varies across different adult CHD types.

Conclusions:

  • Further research is needed to address knowledge gaps in AF management for adult CHD.
  • Personalized approaches to AF ablation are crucial for this heterogeneous patient group.
  • Optimizing AF burden reduction in adult CHD requires innovative strategies and continued investigation.

Keywords:
ablationatrial fibrillationcongenital heart disease

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...